Traditional Chinese medicine for treating diabetic peripheral neuropathy

Abstract

The invention relates to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating diabetic peripheral neuropathy. The traditional Chinese medicine for treating diabetic peripheral neuropathy mainly comprises the following raw materials in parts by weight: 25 g of raw astragali radix, 10 g of polygonatum kingianum, 10 g of common floweringqince fruits, 15 g of salviae miltiorrhizae, 10 g of angelica sinensis, 15 g of caulis spatholobi, 10 g of radix paeoniae alba, 10 g of radix achyranthis bidentatae, 5 g of pangolin, 5 g of scorpion, 10 g of cassia twig, and 8 g of caesalpinia sappan. A traditional Chinese medicine decoction disclosed by the invention treats diabetic peripheral neuropathy through clinical application for many years, and has the effects of supplementing qi and nourishing yin, and promoting blood circulation to remove meridian obstruction. The traditional Chinese medicine for treating diabetic peripheral neuropathy is exact and significant in curative effect, and has no toxic and side effect, and the cure rate is 97.5%, therefore, the traditional Chinese medicine is worth promoting.

Description

(1) Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating diabetic peripheral neuropathy. (2) Background technology [0002] Diabetic Peripheral Neuropathy (DPN), hereinafter referred to as DPN, refers to symptoms and (or) signs related to peripheral nerve dysfunction in diabetic patients when other causes are excluded. The main manifestations are: symmetrical pain, numbness, paresthesia, and muscle atrophy in the extremities, which can cause sensory ataxia, and painless ulcers and neurogenic osteoarthropathy may occur due to repeated minor trauma, infection, and insufficient blood supply. It is one of the important causes of diabetes disability. [0003] At present, the pathogenesis of DPN is not yet fully understood, mainly involving the activation of polyol pathways, non-enzymatic protein glycosylation, oxidative stress, vascular factors, and the lack of nerve growth factor...

AI Technical Summary

Problems solved by technology

Western medicine mostly adopts methods of controlling blood sugar, nourishing nerves, improving microcirculation, anti-oxidative stress, and symptomatic treatment. The main drugs are methylcobaltammonium, alpha-lipoic acid, prostaglandin E2, epalrestat, neurotrophic factor Carbamazepine, amitriptyline, etc. These drugs can play a certain role in the treatment of different pathogenesis of DPN, but for difficult cases with a long course of disease and serious conditions, the curative effect is not satisfactory, some drugs are expensive, and it is difficult to promote clinically application